ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 703174 Null 0.024108502230778 0.066188447
NSC 708062 Null 0.024108502230778 0.27967441
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.024108502230778 0.13238732
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.024108502230778 0.39246842
NSC 99733 Rheumygin 0.024108502230778 0.21754997
NSC 142475 Null 0.0241085022307781 0.11534013
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0241085022307781 0.62772091
NSC 331935 CHALCONE ANALOG 0.024797903481211 0.30468745
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.024797903481211 0.67136626
NSC 625731 Null 0.024797903481211 0.018505945
Total:99  Current:56    [First] [Prev] [Next] [Last]